The effect of metformin on Type 1 (insulin-dependent) diabetes has been assessed with the artificial pancreas. Fourteen Type 1 diabetic patients of normal body weight received in addition to their usual insulin therapy 850 mg metformin or placebo three times a day for 4-6 weeks. The sequence was pla
Sulphonylurea and insulin: combined treatment in Type 1 (insulin-dependent) diabetes
β Scribed by B. J. Burke
- Publisher
- Springer
- Year
- 1985
- Tongue
- English
- Weight
- 124 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sensitivity to insulin in vivo was studied in six Type 1 diabetic patients without residual insulin secretion and without clinical insulin resistance, and in eight non-diabetic subjects, using the euglycaemic insulin clamp technique. Insulin was infused for four periods of 2 h sequentially at 0.5, 1
Patients with Type 1 (insulin-dependent) diabetes without proteinuria were studied to define those patients who will later develop persistent proteinuria (more than 0.5 g protein/24 h). Two investigations were performed; 71 patients were studied longitudinally for 6 years and another 227 patients we
## Abstract In this study we evaluated which injection time is preferable: morning or evening insulin in the combination glibenclamide plus a single lowβdose injection of biphasic insulin (Insuman Combitard 25/75) in Type 2 patients with secondary failure to sulphonylurea treatment. Forty one patie